3D co-cultures of primary human hepatocytes and Kupffer-like cells to address innate immune responses to rAAV
Recombinant adeno-associated viruses (rAAVs) are a platform of choice for gene therapy. However, liver-directed transduction has been hindered by immune responses unpredicted in the pre-clinical models, resulting in therapy failure. Liver immune responses are strictly regulated by the interactions between hepatocytes and non-parenchymal liver cells, such as Kupffer cells (the liver-resident macrophages) but how rAAVs induce such responses remains largely unknown. Therefore, human models recapitulating such interactions are required to address innate immune responses. Here, we developed a human 3D model to characterize the contribution of hepatocytes and Kupffer cells to the innate immune response. We developed a strategy for the differentiation of Kupffer-like cells from circulating monocytes based on cell-cell contact with primary human hepatocytes. We fine-tuned critical co-culture parameters to obtain a Kupffer-like phenotype while retaining hepatocyte viability and identity. Functional assessment of the differentiated 3D co-cultures showed that the model is responsive to classical pathogen-associated molecular pattern molecules, at a gene expression and secretory level. Moreover, we observed increased proinflammatory cytokine expression and secretion when challenged with a rAAV vector. Our data indicate the suitability of the novel model to investigate hepatocyte-Kupffer cell interactions and address innate immune responses within a human liver microenvironment.
Authors
- Catarina Freitas (ORCID: https://orcid.org/0000-0002-3393-5326)
- Inês Correia (ORCID: https://orcid.org/0000-0003-1863-9489)
- Isabella Ramella Gal (ORCID: https://orcid.org/0000-0002-4558-2767)
- Udo Maier
- Sofia Fernandes (ORCID: https://orcid.org/0000-0002-9035-793X)
- Paula M. Alves (ORCID: https://orcid.org/0000-0003-1445-3556)
- Francisca Arez
- Ana S. Coroadinha (ORCID: https://orcid.org/0000-0001-9728-6890)
- Catarina Brito (ORCID: https://orcid.org/0000-0002-8926-279X)
- Nádia Duarte (ORCID: https://orcid.org/0000-0002-4477-4492)
- Giacomo Domenici (ORCID: https://orcid.org/0000-0002-3947-5930)
- Inês Saldanha (ORCID: https://orcid.org/0000-0001-5842-6715)
- Gabriela Silva (ORCID: https://orcid.org/0000-0002-7479-8540)
- François du Plessis (ORCID: https://orcid.org/0000-0001-7096-4807)
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Instituto de Biologia Experimental e Tecnológica (PT)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1038/s41598-025-31044-8
- Citations
- 1
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Ministério da Ciência, Tecnologia e Ensino Superior
- Fundação para a Ciência e a Tecnologia